Individual hormone replacement therapy

Maturitas

Volumn 23, Issue SUPPL., 1996, Pages

  Tuimala, Risto J ^a   Vihtamäki, Tarja ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Estrogen replacement treatment (ERT); Hormone replacement therapy (HRT); Individual

Indexed keywords

ESTRADIOL; ESTROGEN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; DISEASE CONTROL; DOSE RESPONSE; ESTRADIOL BLOOD LEVEL; FEMALE; HORMONE SUBSTITUTION; HUMAN; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PATIENT COMPLIANCE; SYMPTOMATOLOGY; TREATMENT PLANNING;

EID: 0343807213     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5122(96)01019-5     Document Type: Article

References (12)

1. Vihtamäki T. Ylöjärvi study. Personal communication. 1995.
2. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 1995; 87: 34-40.
3. Simon JA. Estrogen pharmacokinetics: interindividual variations. In: Hormone replacement therapy: standardized or individually adapted doses? SS. 9-21. ISBN 1-85070-545-3. Parthenon Publishing Group, London, 1994.
4. Coope J, Marsh J. Can we improve compliance with long-term HRT? Maturitas 1992; 15: 151-158.
5. Scott RT, Ross B, Anderson C, Archer DF. Pharmacokinetics of percutaneous estradiol: a crossover study using a gel and a transdermal system in comparison with oral micronized estradiol. Obstet Gynecol 1991; 77: 758-764.
6. Kuhn W, Gansau C, Mahler M. Pharmacokinetics of estradiol, free and total estrone, in young women following single intravenous and oral administration of 17β-estradiol. Arzneim Forsch/Drug Res 1993; 43: 966-973.
7. Foidart JM, Dombrowicz R, Greimers R, Smet M, de Lignières B. Endometrial tolerance of long-term combined hormone replacement therapy: analysis of the cell cycle. In: Hormone replacement therapy: standardized or individually adapted doses? SS. 47-58. ISBN 1-85070-545-3. Parthenon Publishing Group, London, 1994.
8. Williams JK, Shively CA, Clarkson TB. Determinants of coronary artery reactivity in premenopausal female cynomolgus monkeys with diet-induced atherosclerosis. Circulation 1994; 90: 983-987.
9. Vihtamäki T, Savilahti R, Elo H, Parantainen J, Tuimala R. Can climacteric women adapt therapeutical estrogen dose using their own symptoms as a marker. 10th Congress of European Association of Gynecologists and Obstetricians 29 March-1 April 1995, Monaco. Abstract p. 125.
10. Vihtamäki T, Savilahti R, Tuimala R. Are estrogenic side-effects an indicator of superphysiological serum estradiol levels during HRT? International Menopause Symposium 23-24 March 1995, Tampere. Finland. Abstract p. 25.
11. Luoto R. Hysterectomy in Finland. In: Hysterectomy in Finland. Thesis. National Research and Development Centre for Welfare and Health, Research Reports 49. ISBN 951-47-9619-5. Gummerus Oy, Jyväskyla, 1995.
12. Isaacs AJ, Britton AR, McPherson K. Utilisation of hormone replacement therapy by women doctors. Br Med J 1995; 311: 1399-1401.